Metraipolis › archive › dc_cfbba903b92e
Mitigating Blue-Light Risk in Display-Based Digital Therapeutics: A Practical Framework to Support Clinical Efficacy — Europe PMC PMID:41753059
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41753059
- DOI
- 10.3390/jcm15041371
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T00:47:13.316Z
- SHA-256 of the archived text
4d5de9e3c4ff96cedbd8813e2ce86fd9595435745bea9c4f42862c7a665d0daf- Stable URL of this page
https://metraipolis.com/documento/dc_cfbba903b92e
How to cite
Mitigating Blue-Light Risk in Display-Based Digital Therapeutics: A Practical Framework to Support Clinical Efficacy — Europe PMC PMID:41753059 — Europe PMC (en), https://europepmc.org/article/MED/41753059 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cfbba903b92e (Metraipolis archive dc_cfbba903b92e, sha256 4d5de9e3c4ff96cedbd8813e2ce86fd9595435745bea9c4f42862c7a665d0daf)
BibTeX
@misc{dccfbba903b92e,
title = {Mitigating Blue-Light Risk in Display-Based Digital Therapeutics: A Practical Framework to Support Clinical Efficacy — Europe PMC PMID:41753059},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41753059},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cfbba903b92e; sha256 4d5de9e3c4ff96cedbd8813e2ce86fd9595435745bea9c4f42862c7a665d0daf},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41753059. Agents can read the archived copy with the MCP tool read_document.